Trial Profile
Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety Following Administration of CJ-30059 and Co-administration of Candesartan Cilexetil and Amlodipine Besylate in Healthy Volunteers.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine; Candesartan cilexetil
- Indications Angina pectoris; Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 17 Jul 2014 New trial record